Blood cancers

New drug listed for chronic myeloid leukaemia

The Health Minister has announced the PBS listing of ponatinib (Iclusig) for the treatment for Chronic Myeloid Leukaemia and Acute Lymphoblastic Leukaemia. “Access to new medicines is crucial if we’re to help Australians beat life threatening diseases, which so often can rob them of their independence,” said Ms Ley in a statement. “This $20 million investment ...

Already a member?

Login to keep reading.

© 2021 the limbic